Janux Therapeutics, Inc.Janux Therapeutics, Inc.Janux Therapeutics, Inc.

Janux Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

JANX fundamenta

Janux Therapeutics, Inc. earnings per share and revenue

JANX earnings per share for the last quarter are -0.30 USD whereas the estimation was -0.33 USD which accounts for 9.43% surprise. Företagets omsättning för samma period uppgår till 1.25 M USD trots den uppskattade siffran 878.57 k USD. Estimated earnings per share for the next quarter are -0.31 USD, and revenue is expected to reach 668.50 k USD. Also watch annual changes over time to get a bigger picture of JANX earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning